These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17245174)

  • 1. Insulin sensitivity and mitochondrial function are improved in children with burn injury during a randomized controlled trial of fenofibrate.
    Cree MG; Zwetsloot JJ; Herndon DN; Qian T; Morio B; Fram R; Sanford AP; Aarsland A; Wolfe RR
    Ann Surg; 2007 Feb; 245(2):214-21. PubMed ID: 17245174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The peroxisome proliferator-activated receptor alpha agonist fenofibrate has no effect on insulin sensitivity compared to atorvastatin in type 2 diabetes mellitus; a randomised, double-blind controlled trial.
    Black RN; Ennis CN; Young IS; Hunter SJ; Atkinson AB; Bell PM
    J Diabetes Complications; 2014; 28(3):323-7. PubMed ID: 24560135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive insulin therapy improves insulin sensitivity and mitochondrial function in severely burned children.
    Fram RY; Cree MG; Wolfe RR; Mlcak RP; Qian T; Chinkes DL; Herndon DN
    Crit Care Med; 2010 Jun; 38(6):1475-83. PubMed ID: 20400899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the PPAR-α agonist fenofibrate in severe pediatric burn.
    Elijah IE; Børsheim E; Maybauer DM; Finnerty CC; Herndon DN; Maybauer MO
    Burns; 2012 Jun; 38(4):481-6. PubMed ID: 22226866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels.
    Haluzik MM; Lacinova Z; Dolinkova M; Haluzikova D; Housa D; Horinek A; Vernerova Z; Kumstyrova T; Haluzik M
    Endocrinology; 2006 Sep; 147(9):4517-24. PubMed ID: 16740970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome.
    Belfort R; Berria R; Cornell J; Cusi K
    J Clin Endocrinol Metab; 2010 Feb; 95(2):829-36. PubMed ID: 20061429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of fat metabolism in burn trauma-induced skeletal muscle insulin resistance.
    Cree MG; Aarsland A; Herndon DN; Wolfe RR
    Crit Care Med; 2007 Sep; 35(9 Suppl):S476-83. PubMed ID: 17713396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials.
    Nissen SE; Nicholls SJ; Wolski K; Howey DC; McErlean E; Wang MD; Gomez EV; Russo JM
    JAMA; 2007 Mar; 297(12):1362-73. PubMed ID: 17384435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal Muscle Mitochondrial Function is Determined by Burn Severity, Sex, and Sepsis, and is Associated With Glucose Metabolism and Functional Capacity in Burned Children.
    Rontoyanni VG; Malagaris I; Herndon DN; Rivas E; Capek KD; Delgadillo AD; Bhattarai N; Elizondo A; Voigt CD; Finnerty CC; Suman OE; Porter C
    Shock; 2018 Aug; 50(2):141-148. PubMed ID: 29206761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle mitochondria exhibit decreased pyruvate oxidation capacity and increased ROS emission during surgery-induced acute insulin resistance.
    Hagve M; Gjessing PF; Fuskevåg OM; Larsen TS; Irtun Ø
    Am J Physiol Endocrinol Metab; 2015 Apr; 308(8):E613-20. PubMed ID: 25670828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of PPAR-alpha agonist fenofibrate on insulin sensitivity and selected adipose tissue-derived hormones in obese women with type 2 diabetes.
    Anderlová K; Dolezalová R; Housová J; Bosanská L; Haluzíková D; Kremen J; Skrha J; Haluzík M
    Physiol Res; 2007; 56(5):579-586. PubMed ID: 17184146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum adipocyte fatty acid binding protein levels in patients with type 2 diabetes mellitus and obesity: the influence of fenofibrate treatment.
    Haluzík MM; Anderlová K; Doležalová R; Adamíková A; Haluzíková D; Housová J; Svacina S; Haluzík M
    Physiol Res; 2009; 58(1):93-99. PubMed ID: 18198986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance postburn: underlying mechanisms and current therapeutic strategies.
    Gauglitz GG; Herndon DN; Jeschke MG
    J Burn Care Res; 2008; 29(5):683-94. PubMed ID: 18695610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR partly mediates insulin resistance by phosphorylation of insulin receptor substrate-1 on serine(307) residues after burn.
    Xin-Long C; Zhao-Fan X; Dao-Feng B; Wei D
    Burns; 2011 Feb; 37(1):86-93. PubMed ID: 20594757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose.
    Buldak L; Dulawa-Buldak A; Labuzek K; Okopien B
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):805-13. PubMed ID: 22943927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone-induced improvements in insulin sensitivity occur without concomitant changes in muscle mitochondrial function.
    Bajpeyi S; Pasarica M; Conley KE; Newcomer BR; Jubrias SA; Gamboa C; Murray K; Sereda O; Sparks LM; Smith SR
    Metabolism; 2017 Apr; 69():24-32. PubMed ID: 28285649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus.
    Mensink M; Hesselink MK; Russell AP; Schaart G; Sels JP; Schrauwen P
    Int J Obes (Lond); 2007 Aug; 31(8):1302-10. PubMed ID: 17310221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute insulin resistance mediated by advanced glycation endproducts in severely burned rats.
    Zhang X; Xu J; Cai X; Ji L; Li J; Cao B; Li J; Hu D; Li Y; Wang H; Xiong L; Xiao R; Gao F
    Crit Care Med; 2014 Jun; 42(6):e472-80. PubMed ID: 24670938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma triglycerides are not related to tissue lipids and insulin sensitivity in elderly following PPAR-alpha agonist treatment.
    Cree MG; Newcomer BR; Read LK; Sheffield-Moore M; Paddon-Jones D; Chinkes D; Aarsland A; Wolfe RR
    Mech Ageing Dev; 2007 Oct; 128(10):558-65. PubMed ID: 17904198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
    Vega GL; Cater NB; Hadizadeh DR; Meguro S; Grundy SM
    Clin Pharmacol Ther; 2003 Sep; 74(3):236-44. PubMed ID: 12966367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.